CD8A and Alzheimer disease: Consistent with this, several studies have reported increased numbers of parenchymal and peripheral CD8+ T cells in AD patients, shedding light on a potential role for MHC class I molecules in AD (Larbi et al., 2009; Lueg et al., 2015; Unger et al., 2020).